Nivolumab-induced hypothyroidism and selective pituitary insufficiency in a patient with lung adenocarcinoma: a case report and review of the literature

Immune checkpoint blockade including programmed cell death 1 pathway inhibition with agents such as nivolumab is gaining ground in a wide array of malignancies, so far demonstrating significantly improved survival rates even in metastatic, often multiply pretreated settings. Although targeted in nat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:ESMO Open
Main Authors: Kastrisiou, Myrto, Kostadima, Fereniki-Lida, Kefas, Aristides, Zarkavelis, George, Kapodistrias, Nikos, Ntouvelis, Evangelos, Petrakis, Dimitrios, Papadaki, Alexandra, Vassou, Amalia, Pentheroudakis, George
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2017
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5640091/
https://ncbi.nlm.nih.gov/pubmed/29067215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2017-000217
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados